Payment overview · 2025
General Payments
$16.06
1 reported records · 1 companies
Healthcare provider profile · identity verified
Leonor M Osorio, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · CLEVELAND, OH · NPI 1568451847
Verified facts
What the public records show
CMS Open Payments records show Leonor M Osorio, D.O. received $16.06 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $16.06 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.06 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $16.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 438 | 142 |
| Losartan Potassium | Losartan Potassium | 313 | 105 |
| Omeprazole | Omeprazole | 276 | 88 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 276 | 92 |
| Gabapentin | Gabapentin | 246 | 91 |
| Amlodipine Besylate | Amlodipine Besylate | 235 | 82 |
| Metformin Hcl | Metformin Hcl | 228 | 75 |
| Tramadol Hcl | Tramadol Hcl | 219 | 33 |
| Levothyroxine Sodium | Levothyroxine Sodium | 206 | 59 |
| Ozempic | Semaglutide | 189 | 36 |
| Lisinopril | Lisinopril | 180 | 54 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 175 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 172 | 77 |
| Famotidine | Famotidine | 156 | 53 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 147 | 53 |
| Simvastatin | Simvastatin | 139 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 138 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 131 | 48 |
| Valsartan | Valsartan | 120 | 51 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 116 | 51 |
| Trulicity | Dulaglutide | 111 | 27 |
| Baclofen | Baclofen | 106 | 49 |
| Montelukast Sodium | Montelukast Sodium | 106 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 100 | 32 |
| Ibuprofen | Ibuprofen | 94 | 34 |
| Mirtazapine | Mirtazapine | 93 | 37 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 91 | 36 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 37 |
| Meclizine Hcl | Meclizine Hcl | 77 | 33 |
| Alprazolam | Alprazolam | 68 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 64 | 23 |
| Januvia | Sitagliptin Phosphate | 62 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 62 | 29 |
| Celecoxib | Celecoxib | 61 | 15 |
| Farxiga | Dapagliflozin Propanediol | 61 | 14 |
| Trazodone Hcl | Trazodone Hcl | 61 | 20 |
| Mounjaro | Tirzepatide | 60 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | 20 |
| Alendronate Sodium | Alendronate Sodium | 55 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 54 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 53 | 19 |
| Jardiance | Empagliflozin | 53 | 21 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 53 | 15 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 53 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 52 | 13 |
| Pregabalin | Pregabalin | 52 | 12 |
| Nystatin | Nystatin | 51 | 24 |
| Nitroglycerin | Nitroglycerin | 50 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 50 | 21 |
| Eliquis | Apixaban | 49 | 11 |
| Furosemide | Furosemide | 48 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | 12 |
| Lidocaine | Lidocaine | 43 | 12 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 42 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 19 |
| Atenolol | Atenolol | 39 | suppressed |
| Carvedilol | Carvedilol | 38 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 38 | 12 |
| Linzess | Linaclotide | 36 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 36 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Allopurinol | Allopurinol | 34 | 14 |
| Ventolin Hfa | Albuterol Sulfate | 34 | 14 |
| Buspirone Hcl | Buspirone Hcl | 33 | suppressed |
| Hydrocortisone | Hydrocortisone | 33 | 15 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 33 | 13 |
| Metformin Hcl Er | Metformin Hcl | 32 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | suppressed |
| Memantine Hcl | Memantine Hcl | 31 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 31 | 21 |
| Ammonium Lactate | Ammonium Lactate | 30 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | 15 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 27 | 16 |
| Azelastine Hcl | Azelastine Hcl | 27 | 11 |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Prednisone | Prednisone | 27 | 22 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Spironolactone | Spironolactone | 24 | 12 |
| Telmisartan | Telmisartan | 24 | suppressed |
| Finasteride | Finasteride | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Vascepa | Icosapent Ethyl | 23 | suppressed |
| Sucralfate | Sucralfate | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 20 |
| Ketoconazole | Ketoconazole | 21 | 12 |
| Trulance | Plecanatide | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Potassium Chloride | Potassium Chloride | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Desoximetasone | Desoximetasone | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 17 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Meloxicam | Meloxicam | 17 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 17 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 15 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Roflumilast | Roflumilast | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.06 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error